Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Janey C. Peterson, MA, MS, RN, EdD

Advertisement

Articles by Janey C. Peterson, MA, MS, RN, EdD

There's an App for That: Keeping Patients and Physicians on Track

ByJaney C. Peterson, MA, MS, RN, EdD,Brendon Stiles, MD,Heather Yeo, MD, MHS
September 19th 2016

Using mobile apps and other new technologies, clinicians can better monitor and help their patients.

Advertisement

Latest Updated Articles

  • There's an App for That: Keeping Patients and Physicians on Track
    There's an App for That: Keeping Patients and Physicians on Track

    September 19th 2016



Advertisement
Advertisement

Trending on Oncology Nursing News

1

Exercise May Reverse Obesity-Induced Immune Suppression in Lung Cancer

2

mRNA Cancer Vaccine Met Endpoints in Adjuvant Melanoma

3

Daraxonrasib Approved: What Oncology Nurses Must Know About Rasonque

4

FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma

5

Individualizing Frontline Treatment Selection in Metastatic Triple-Negative Breast Cancer

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us